These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Mutation analysis of the tyrosinase gene in oculocutaneous albinism. Camand O; Marchant D; Boutboul S; Péquignot M; Odent S; Dollfus H; Sutherland J; Levin A; Menasche M; Marsac C; Dufier JL; Heon E; Abitbol M Hum Mutat; 2001 Apr; 17(4):352. PubMed ID: 11295837 [TBL] [Abstract][Full Text] [Related]
4. [Human oculocutaneous albinism. From clinical observation to molecular biology]. Aquaron R Bull Soc Pathol Exot; 1993; 86(5):313-26. PubMed ID: 8124097 [TBL] [Abstract][Full Text] [Related]
5. Albinism and its implications with vision. Kirkwood BJ Insight; 2009; 34(2):13-6. PubMed ID: 19534229 [TBL] [Abstract][Full Text] [Related]
6. [Normalization of melanin synthesis in the ocular pigment epithelium of albino ap toad embryos]. Khoperskaia OA Dokl Akad Nauk SSSR; 1977; 236(4):998-100. PubMed ID: 923426 [No Abstract] [Full Text] [Related]
7. Oculocutaneous albinism type 1A: a case report. Karaman A Dermatol Online J; 2008 Nov; 14(11):13. PubMed ID: 19094851 [TBL] [Abstract][Full Text] [Related]
8. [Hereditary anomalies of melanin metabolism (apropos of 5 cases)]. Geormăneanu M; Sanielevici-Marinov S; Mark E; Gârbacea G; Gherghina I Pediatria (Bucur); 1972; 21(4):327-34. PubMed ID: 4661110 [No Abstract] [Full Text] [Related]
9. Hairbulb tyrosinase activity in oculocutaneous albinism: suggestions for pathway control and block location. King RA; Olds DP Am J Med Genet; 1985 Jan; 20(1):49-55. PubMed ID: 3918447 [TBL] [Abstract][Full Text] [Related]
10. A critical review of the function of neuromelanin and an attempt to provide a unified theory. Nicolaus BJ Med Hypotheses; 2005; 65(4):791-6. PubMed ID: 15949901 [TBL] [Abstract][Full Text] [Related]
11. A review of genetic disorders of hypopigmentation: lessons learned from the biology of melanocytes. Dessinioti C; Stratigos AJ; Rigopoulos D; Katsambas AD Exp Dermatol; 2009 Sep; 18(9):741-9. PubMed ID: 19555431 [TBL] [Abstract][Full Text] [Related]
12. Molecular genetics of oculocutaneous albinism. Spritz RA Semin Dermatol; 1993 Sep; 12(3):167-72. PubMed ID: 8217557 [TBL] [Abstract][Full Text] [Related]
13. Molecular basis of type I (tyrosinase-related) oculocutaneous albinism: mutations and polymorphisms of the human tyrosinase gene. Oetting WS; King RA Hum Mutat; 1993; 2(1):1-6. PubMed ID: 8477259 [TBL] [Abstract][Full Text] [Related]
14. [Oculo-cutaneous albinism in man. Biochemical, genetic, clinical, and population aspects]. Cassero C; Montana R Arch Sci Med (Torino); 1983; 140(2):105-26. PubMed ID: 6882187 [TBL] [Abstract][Full Text] [Related]
15. [Oculocutaneous albinism and tyrosinuria. Description of a clinical case]. Assensio AM; Cascone C; Fracassi A; Parisi SG; Lubrano R; Giardini O Minerva Pediatr; 1983 Feb; 35(3):99-103. PubMed ID: 6843532 [No Abstract] [Full Text] [Related]
16. Genetics of pigmentary disorders. Tomita Y; Suzuki T Am J Med Genet C Semin Med Genet; 2004 Nov; 131C(1):75-81. PubMed ID: 15452859 [TBL] [Abstract][Full Text] [Related]
17. The actions of melanin and melanocyte stimulating hormone (MSH). Rasmussen N; Nelson F; Govitrapong P; Ebadi M Neuro Endocrinol Lett; 1999; 20(5):265-282. PubMed ID: 11460086 [TBL] [Abstract][Full Text] [Related]
18. Hypopigmentation in Angelman syndrome. King RA; Wiesner GL; Townsend D; White JG Am J Med Genet; 1993 Apr; 46(1):40-4. PubMed ID: 8494033 [TBL] [Abstract][Full Text] [Related]
19. Biochemical aspects of human albinism. Winder AF; Jay B; Kissun RD Birth Defects Orig Artic Ser; 1976; 12(3):427-40. PubMed ID: 821564 [No Abstract] [Full Text] [Related]
20. The biology of the pigmentary system and its disorders. Lucky PA; Nordlund JJ Dermatol Clin; 1985 Apr; 3(2):197-216. PubMed ID: 3913546 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]